Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Long-term Depression

Long-term Depression

Long-term depression, or LTD, is one of the ways by which synaptic plasticity—changes in the strength of chemical synapses—can occur in the brain. LTD is the process of synaptic weakening that occurs over time between pre and postsynaptic neuronal connections. The synaptic weakening of LTD works in opposition to synaptic strengthening by long-term potentiation (LTP) and together are the main mechanisms that underlie learning and memory.
Calcium Ion Concentration Mechanism
If over time, all...

Drug Dosing: Geriatric Patients

Drug Dosing: Geriatric Patients

Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption

As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...

Pharmacodynamics in Geriatric Patients: Effects of Age

Pharmacodynamics in Geriatric Patients: Effects of Age

Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Publisher Correction: Brain charts for the human lifespan.

Nature·2022

Same author

Brain charts for the human lifespan.

Nature·2022

Same author

Physical Exercise for Late-Life Major Depression.

Focus (American Psychiatric Publishing)·2021

Same author

Vectorizing the spatial structure of high-harmonic radiation from gas.

Nature communications·2019

Same author

Stabilization treatment of remitted psychotic depression: the STOP-PD study.

Acta psychiatrica Scandinavica·2018

Same author

High resolution spectroscopy of six SOCl2 isotopologues from the microwave to the far-infrared.

The Journal of chemical physics·2016

Search research articles

Related Experiment Video

Updated: Jul 13, 2026

P50 Sensory Gating in Infants

P50 Sensory Gating in Infants

Published on: December 26, 2013

P300 latency in geriatric depression

B Kalayam¹, G S Alexopoulos, S Kindermann

¹Department of Psychiatry, Cornell University Medical College, New York, White Plains, USA.

The American Journal of Psychiatry

|March 21, 1998

Summary

Elderly individuals with depression exhibit prolonged P300 latency, linked to cognitive deficits and vascular disease risk factors. These findings suggest vascular contributions to geriatric depression symptoms.

More Related Videos

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Related Experiment Videos

Last Updated: Jul 13, 2026

P50 Sensory Gating in Infants

P50 Sensory Gating in Infants

Published on: December 26, 2013

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Highlighting and Reducing the Impact of Negative Aging Stereotypes During Older Adults' Cognitive Testing

Published on: January 24, 2020

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Association Between Sleep Quality and Cognitive Symptoms in Patients with Major Depressive Disorder

Published on: April 26, 2024

Area of Science:

Neuroscience
Gerontology
Psychiatry

Background:

Late-life depression is a significant concern in geriatric populations.
Vascular disease is increasingly recognized as a contributing factor in cognitive decline and mood disorders.
Understanding the neurophysiological underpinnings of geriatric depression is crucial for effective intervention.

Purpose of the Study:

To investigate if P300 latency is extended in geriatric depression.
To examine the relationship between prolonged P300 latency, cognitive deficits (initiation, perseveration), and vascular disease risk factors in elderly depressed patients.

Main Methods:

A study involving geriatric patients diagnosed with unipolar depression (N=43) and a comparison group of elderly subjects (N=24).
Assessment included evaluation of depressive symptoms, cognitive functions, vascular disease risk factors, and P300 event-related potential latency.

Main Results:

Depressed elderly patients demonstrated significantly longer P300 latency compared to healthy elderly controls.
In the depressed group, P300 latency correlated with deficits in initiation and errors of perseveration.
Vascular disease risk factors were associated with both prolonged P300 latency and these specific cognitive deficits.

Conclusions:

Vascular-related functional impairment in cortico-striato-pallido-thalamo-cortical pathways may underlie prolonged P300 latency and cognitive deficits in geriatric depression.
These preliminary findings suggest a potential neurobiological link between vascular health and depressive symptomatology in the elderly.
Further research utilizing brain imaging and advanced neuropsychological measures is recommended to validate these results.